Psychemedics Corporation Price & Performance (PMD)

New projections show the global drug screening market is set to rise at a 15% compound annual growth rate through next year. Increased adoption of advanced testing, such as hair analysis in schools and workplaces, is fueling demand. Market expansion is driven by both regulatory requirements and growing employer focus on safety.12

Psychemedics Corporation has launched a quartile reporting feature, providing organizations with detailed benchmarks on drug test results. This advancement allows employers to use data-driven insights for hiring and compliance strategies. The company continues to lead in hair-based drug detection, serving major corporations and educational institutions nationwide.34

Following shareholder approval, Psychemedics Corporation executed a 1-for-5,000 reverse stock split immediately followed by a 5,000-for-1 forward split. Holders of fewer than 5,000 shares received $2.35 per share in cash, effectively streamlining the shareholder base while maintaining overall ownership for larger investors.56